Riskpilot← Back to searchSign inGet full accessUvisa Health ApS
APSActiveCVR 42444383Boltonvej 21AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20214 employeeswww.uvisahealth.com
Revenue 2024
DKK -1,8M
-1608% vs 2023
EBITDA margin
207.0%
-242% vs 2023
Equity ratio
19.0%
Financial strength
Net profit 2024
DKK -3M
-262% vs 2023
| Revenue | DKK -1,8M | -1608% |
| EBITDA | DKK -3,7M | -242% |
| Net profit | DKK -3M | -262% |
| Total assets | DKK 2,9M | +260% |
| Equity | DKK 557K | +206% |
| Employees | 4 | — |
Legal name
Uvisa Health ApS
CVR number
42444383
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. juni 2021
Share capital
DKK 52.169
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af en direktør alene
Company purpose
Selskabets formål er at drive virksomhed med handel, forskning og udvikling, service og produktion samt al virksomhed, som efter bestyrelsens skøn har forbindelse hermed
Address
Boltonvej 21A
Email
hello@uvisahealth.com
Website
www.uvisahealth.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 73 | 119 | -1.792 |
| Staff expenses | -0 | -237 | -1.203 | -1.917 |
| EBITDA | -39 | -164 | -1.084 | -3.709 |
| Depreciation & amort. | -0 | -1 | -1 | -0 |
| EBIT | -39 | -165 | -1.085 | -3.709 |
| Net financials | 319 | -3 | -33 | -131 |
| Profit before tax | 280 | -167 | -1.117 | -3.839 |
| Tax | 67 | -229 | -280 | -811 |
| Net profit | 213 | 62 | -838 | -3.029 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 428 | 346 | 816 | 2.938 |
| Equity | 253 | 314 | -523 | 557 |
| Long-term debt | 0 | 0 | 1.031 | 2.221 |
| Short-term debt | 168 | 31 | 305 | 161 |
| Total debt | 168 | 31 | 1.337 | 2.382 |
EBITDA margin
-370856600.0%
This company
15.8%
Market median
-2347193771% vs market
20212024
Equity ratio
19.0%
This company
38.2%
Market median
-50% vs market
20212024
Return on equity
-543.9%
This company
18.4%
Market median
-3056% vs market
20212024
Net profit margin
-302878500.0%
This company
8.1%
Market median
-3739240841% vs market
20212024
Asset turnover
-0.61×
This company
1.12×
Market median
-154% vs market
20212024
Debt / equity
4.28×
This company
0.62×
Market median
-590% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-06-07 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EJ Management | Management | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Chairman | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (3) | ||
| Deputy Chairman | 2024 – 2025 | |
| Chairman | 2023 – 2025 | |
| Board of Directors | 2024 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2024 | |
| Company | 15–19.99% | 15–19.99% | 2024 | |
| Company | 10–14.99% | 10–14.99% | 2024 | |
| Company | 5–9.99% | 5–9.99% | 2024 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Borring Capital ApS
Uvisa Health ApS Board members of Uvisa Health ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ella Jade Smoraczewska Harris | Management | 0 companies |
| Jens Staahl Weirsøe | Deputy Chairman | 0 companies |
| Karoline Tetlie Akerjordet | Chairman | 0 companies |
| Anders Borring | Board of Directors | 0 companies |
| Malene Schrøder | Deputy Chairman | 0 companies |
| Erica Perrier | Board of Directors | 0 companies |
| Jesper Ahlmann Funding Andersen | Chairman | 0 companies |